Human immunodeficiency virus type 1 Tat-mediated cytotoxicity of human brain microvascular endothelial cells

Journal of NeuroVirology

Volumn 9, Issue 6, 2003, Pages 584-593

  Khan, Naveed Ahmed ^a   Di Cello, Francescopaolo ^a   Nath, Avi ^b   Kim, Kwang Sik ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Human brain microvascular endothelial cells; IFN gamma; PI3K; Tat; VEGFR2 KDR

Indexed keywords

GAMMA INTERFERON; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSACTIVATOR PROTEIN; VASCULOTROPIN RECEPTOR 2;

BLOOD BRAIN BARRIER; BRAIN DISEASE; CEREBROSPINAL FLUID; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROVASCULARIZATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REVIEW; UPREGULATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0346777325     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/jnv.9.6.584.593     Document Type: Review

References (64)

1. Abedi H, Zachary I (1997). Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J Biol Chem 272: 15442-15451.
2. Albini A, Ferrini S, Benelli R, Sforzini S, Giunciuglio D, Aluigi MG, Proudfoot AE, Alouani S, Wells TN, Mariani G, Rabin RL, Farber JM, Noonan DM (1998). HIV-1 Tat protein mimicry of chemokines. Proc Natl Acad Sci U S A 95: 13153-13158.
3. Annunziata P, Cioni C, Toneatto S, Paccagnini E (1998). HIV-1 gp120 increases the permeability of rat brain endothelium cultures by a mechanism involving substance P. AIDS 12: 2377-2385.
4. Banks WA, Kastin AJ, Akerstrom V (1997). HIV-1 protein gp120 crosses the blood-brain barrier: role of adsorptive endocytosis. Life Sci 61: PL119-PL125.
5. Barillari G, Gendelman R, Gallo RC, Ensoli B (1993). The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci U S A 90: 7941-7945.
6. Barillari G, Sgadari C, Palladino C, Gendelman R, Caputo A, Morris CB, Nair BC, Markham P, Nel A, Sturzl M, Ensoli B (1999). Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin. J Immunol 163: 1929-1935.
7. Benyoucef S, Hober D, De Groote D, De La Tribonniere X, Vilain V, Lion G, Bouzidi A, Wattre P (1997). An interferon-gamma (IFN-gamma) based whole blood assay to detect T cell response to antigens in HIV-1 infected patients. Pathol Biol (Paris) 5: 400-403.
8. Bussolino F, Mitola S, Serini G, Barillari G, Ensoli B (2001). Interactions between endothelial cells and HIV-1. Int J Biochem Cell Biol 33: 371-390.
9. Claudio L, Martiney JA, Brosnan CF (1994). Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1 beta or tumor necrosis factor-alpha. Lab Invest 70: 850-861.
10. Corasaniti MT, Bagetta G, Rotiroti D, Nistico G (1998). The HIV envelope protein gp120 in the nervous system: interactions with nitric oxide, interleukin-1beta and nerve growth factor signalling, with pathological implications in vivo and in vitro. Biochem Pharmacol 56: 153-156.
11. Dallasta LM, Pisarov LA, Esplen JE, Werley JV, Moses AV, Nelson JA, Achim CL (1999). Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol 155: 1915-1927.
12. Del Sorbo L, Arese M, Giraudo E, Tizzani M, Biancone L, Bussolino F, Camussi G (2001). Tat-induced platelet-activating factor synthesis contributes to the angiogenic effect of HIV-1 Tat. Eur J Immunol 31: 376-383.
13. De Vries HE, Blom-Roosemalen MC, van Oosten M, de Boer AG, van Berkel TJ, Breimer DD, Kuiper J.(1996). The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol 64: 37-43.
14. Dhawan S, Puri RK, Kumar A, Duplan H, Masson JM, Aggarwal BB (1997). Human immunodeficiency virus-1-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells. Blood 90: 1535-1544.
15. Dougher-Vermazen M, Hulmes JD, Bohlen P, Terman BI (1994). Biological activity and phosphorylation sites of the bacterially expressed cytosolic domain of the KDR VEGF-receptor. Biochem Biophys Res Commun 205: 728-738.
16. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F (1990). Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345: 84-86.
17. Fiorelli V, Barillari G, Toschi E, Sgadari C, Monini P, Sturzl M, Ensoli B (1999). IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: implications for AIDS-Kaposi's sarcoma pathogenesis. J Immunol 162: 1165-1170.
18. Fiorelli V, Gendelman R, Samaniego F, Markham PD, Ensoli B (1995). Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J Clin Invest 95: 1723-1734.
19. Fiorelli V, Gendelmann R, Sirianni MC, Chang HK, Colombini S, Markham PD, Monini P, Sonnabend J, Pintus A, Gallo RC, Ensoli B (1998). gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection? Blood 91: 956-967.
20. Ganju RK, Munshi N, Nair BC, Liu ZY, Gill P, Groopman JE (1998). Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells. J Virol 2: 6131-6137.
21. Gavriil ES, Cooney R, Weeks BS (2002). Tat mediates apoptosis in vivo in the rat central nervous system. Biochem Biophys Res Commun 67: 252-256.
22. Glass JD, Johnson RT (1996). Human immunodeficiency virus and the brain. Annu Rev Neurosci 19: 1-26.
23. Graziosi C, Gantt KR, Vaccarezza M, Demarest JF, Daucher M, Saag MS, Shaw GM, Quinn TC, Cohen CJ, Welbon CC, Pantaleo G, Fauci AS (1996). Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection. Proc Natl Acad Sci U S A 93: 4386-4391.
24. Hofman FM, Chen P, Incardona F, Zidovetzki R, Hinton DR (1999). HIV-1 tat protein induces the production of interleukin-8 by human brain-derived endothelial cells. J Neuroimmunol 94: 28-39.
25. Hofman FM, Wright AD, Dohadwala MM, Wong-Staal F, Walker SM (1993). Exogenous tat protein activates human endothelial cells. Blood 82: 2774-2780.
26. Ivankovic-Dikic I, Gronroos E, Blaukat A, Barth BU, Dikic I (2000). Pyk2 and FAK regulate neurite outgrowth induced by growth factors and integrins. Nat Cell Biol 2: 574-581.
27. Janssen RS (1997). AIDS and the Nervous System, 2nd ed. Philadelphia: Lippincott-Raven, pp 13-37.
28. Jeang KT, Xiao H, Rich EA (1999). Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J Biol Chem 274: 28837-28840.
29. Jia H, Lohr M, Jezequel S, Davis D, Shaikh S, Selwood D, Zachary I (2001). Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis. Biochem Biophys Res Commun 283: 469-479.
30. Jones KA (1993). Tat and the HIV-1 promoter. Curr Opin Cell Biol 5: 461-468.
31. Khan NA, Jarroll EL, Panjwani N, Cao Z, Paget TA (2000). Proteases as markers for differentiation of pathogenic and nonpathogenic species of Acanthamoeba. J Clin Microbiol 38: 2858-2861.
32. Kolb SA, Sporer B, Lahrtz F, Koedel U, Pfister HW, Fontana A (1999). Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10. J Neuroimmunol 93: 172-181.
33. Koppel BS (1998). AIDS and Other Manifestations of HIV Infection. Philadelphia: Lippincott-Raven, pp 431-474.
34. Kruman II, Nath A, Mattson MP (1998). HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol 154: 276-288.
35. Lafrenie RM, Wahl LM, Epstein JS, Yamada KM, Dhawan S (1997). Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression. J Immunol 159: 4077-4083.
36. Lahdevirta J, Maury CPJ, Teppo AM, Repo H (1988). Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 85: 289-291.
37. Ma M, Nath A (1997). Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J Virol 71: 2495-2499.
38. Magnuson DS, Knudsen BE, Geiger JD, Brownstone RM, Nath A (1995). Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 37: 373-380.
39. Marshall DW, Brey RL, Butzin CA, Lucey DR, Abbadessa SM, Boswell RN (1991). CSF changes in a longitudinal study of 124 neurologically normal HIV-1-infected U.S. Air Force personnel. J Acquir Immun Defic Syndr 4: 777-781.
40. McArthur JC, Nance-Sproson TE, Griffin DE, Hoover D, Selnes OA, Miller EN, Margolick JB, Cohen BA, Farzadegan H, Saah A (1992). The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study. Neurology 42: 1707-1712.
41. Mitola S, Soldi R, Zanon I, Barra L, Gutierrez MI, Berkhout B, Giacca M, Bussolino, F (2000). Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells. J Virol 74: 344-353.
42. Morini M, Benelli R, Giunciuglio D, Carlone S, Arena G, Noonan DM, Albini A (2000). Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology. Biochem Biophys Res Commun 273: 267-271.
43. New DR, Ma M, Epstein LG, Nath A, Gelbard HA (1997). Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J Neuro Virol 3: 168-173.
44. Patki AH, Lederman MM (1996). HIV-1 Tat protein and its inhibitor Ro 24-7429 inhibit lymphocyte proliferation and induce apoptosis in peripheral blood mononuclear cells from healthy donors. Cell Immunol 169: 40-46.
45. Persidsky Y, Stins M, Way D, Witte MH, Weinand M, Kim KS, Bock P, Gendelman HE, Fiala M (1997). A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol 158: 3499-3510.
46. Petito CK, Cash KS (1992). Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neural 32: 658-666.
47. Philippon V, Vellutini C, Gambarelli D, Harkiss G, Arbuthnott G, Metzger D, Roubin R, Filippi P (1994). The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines. Virology 205: 519-529.
48. Power C, Kong PA, Crawford CO, Wesselingh S, Glass JD, McArthur JC, Trapp BD (1993). Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 34: 339-350.
49. Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, Dewey R, Chesebro B (1995b). Distinct HIV-1 env sequences are associated with neurotropism and neurovirulence. Curr Top Microbiol Immunol 202: 89-104.
50. Qi JH, Claesson-Welsh L (2001). VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase. Exp Cell Res 263: 173-182.
51. Rappaport J, Joseph J, Croul S, Alexander G, Del Valle L, Amini S, Khalili K (1999). Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat. J Leukoc Biol 65: 458-465.
52. Reddy MA, Prasadarao NV, Wass CA, Kim KS (2000a). Phosphatidylinositol 3-kinase activation and interaction with focal adhesion kinase in Escherichia coli K1 invasion of human brain microvascular endothelial cells. J Biol Chem 275: 36769-36774.
53. Reddy MA, Wass CA, Kim KS, Schlaepfer DD, Prasadarao NV (2000b). Involvement of focal adhesion kinase in Escherichia coli invasion of human brain microvascular endothelial cells. Infect Immun 68: 6423-6430.
54. Rhodes RH (1991). Evidence of serum-protein leakage across the blood-brain barrier in the acquired immunodeficiency syndrome. J Neuropathol Exp Neurol 50: 171-183.
55. Sporer B, Paul R, Koedel U, Grimm R, Wick M, Goebel FD, Pfister HW (1998). Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients. J Infect Dis 178: 854-857.
56. Stins MF, Gilles F, Kim KS (1997). Selective expression of adhesion molecules on human brain microvascular endothelial cells. J Neuroimmunol 76: 81-90.
57. Stins MF, Shen Y, Huang SH, Gilles F, Kalra VK, Kim KS (2001). Gp120 activates children's brain endothelial cells via CD4. J Neuro Virol 7: 125-134.
58. Thakker GD, Hajjar DP, Muller WA, Rosengart TK (1999). The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling. J Biol Chem 274: 10002-10007.
59. Toneatto S, Finco O, van der Putten H, Abrignani S, Annunziata P (1999). Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice. AIDS 13: 2343-2348.
60. Tran Dinh YR, Mamo H, Cervoni J, Caulin C, Saimot AC (1990). Disturbances in the cerebral perfusion of human immune deficiency virus-1 seropositive asymptomatic subjects: a quantitative tomography study of 18 cases. J Nucl Med 31: 1601-1607.
61. Vogel BE, Lee SJ, Hildebrand A, Craig W, Pierschbacher MD, Wong-Staal F, Ruoslahti E (1993). A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin. J Cell Biol 121: 461-468.
62. Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, Debatin KM, Krammer PH (1995). Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375: 497-500.
63. Zauli G, La Placa M, Vignoli M, Re MC, Gibellini D, Furlini G, Milani D, Marchisio M, Mazzoni M, Capitani S (1995). An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity. AIDS 10: 306-316.
64. Zhang GW, Khan NA, Kim KJ, Stins MF, Kim KS (2002). TGF-α increases Escherichia coli K1 adherence, invasion and transcytosis in human brain microvascular endothelial cells. Cell Tissue Res 309: 281-286.